Two lipids in the diet, rather than cholesterol, are responsible for heart failure and stroke

References

• Aird WC. Spatial and temporal dynamics of the endothelium. J. Thrombo. Haemost. 3, 1392–1406 (2005).
   Google Scholar
• Rose WC, Wixom RL, Lockhart HB, Lambert GF. The amino acid requirements of man. XV. The valine requirement; summary and final observations. J. Biol. Chem. 127, 987 (1955).
   Google Scholar
• Kummerow FA. Nutrition imbalance and angiotoxins as dietary risk factors in coronary heart disease. Am. J. Clin. Nutr. 32, 58–83 (1979). • heart failure can occur even without a dietary source of cholesterol.
   Google Scholar
• Bloch K. The biological synthesis of cholesterol. J. Biol. Chem. 1, 79–98 (1964).
   Google Scholar
• Pilgeram L. Atherogenesis and fibrinogen: historical perspective, biochemical mechanism, and current status. Cardio. Eng. 2, 111–128 (2003).
   Google Scholar
• Pilgeram L. Atherogenesis and fibrinogen: historical perspective and current status. Naturwissenschaften 80, 547–555 (1993).
   Google Scholar
• Lindgren FT, Nichols AV. Plasma Proteins (Volume 2). Academic Press Inc., NY, USA (1960).
   Google Scholar
• Baker HN, Jackson RL, Gotto AM Jr. Isolation and characterization of the cyanogen brominde fragments from the high-density apolopoprotein glutamine I. Biochemistry 12, 3866 (1973).
   Google Scholar
• Jackson RL, Morrisett JD, Pownall HJ, Gotto AM Jr. Human high density lipoprotein glutamine II. J. Biol. Chem. 248, 5218 (1973).
   Google Scholar
• Jackson RL, Taunton OD, Segura R, Gallagher JG, Hoff HF, Gotto AM Jr. Comparative studies on plasma low density lipoproteins from pig and man. Comp. Biochem. Physiol. 53b, 245 (1976).
   Google Scholar
• Jackson RL, Sparrow JT, Baker HN, Morrisett JD, Taunton OD, Gotto AM Jr. The primary structure of apolipoproteinserine. J. Biol. Chem. 249, 5308 (1974).
   Google Scholar
• Brown WV, Levy RI, Frederickson DS. Further charaacterization of Apolipoproteins from human plasma very low density lipoproteins. J. Biol. Chem. 245, 6588 (1970).
   Google Scholar
• Morrisett Jd, David SK, Powmall HJ, Gotto AM JR. Interaction of an apolipoprotein (ApoLP-alanine) with phosphatidylcholine. Biochemistry 12, 1290 (1973).
   Google Scholar
• Shore VG, Shore B. Heterogeneity of human plasma very low density lipoproteins. Seperation of species differing in protein components. Biochemistry 12, 502 (1973).
   Google Scholar
• McConathy WJ, Alauppovic P. Isolation and partial characterization of apolipoprotein D: a new protein moiety of the human plasma lipoprotein system. FEBS Lett. 37, 178 (1973).
   Google Scholar
• American Heart Association. What Your Numbers Mean. American Heart Association, TX, USA (2006).
   Google Scholar
• Steinberg D. The Cholesterol Wars. Academic Press Inc., NY, USA (2007).
   Google Scholar
• US Federal Trade Commission Docket #8987. Official transcript of proceedings: National Commission on Egg Nutrition. Washington, DC, USA (1975).
   Google Scholar
• US Federal Trade Commission Docket #8987. Final order. National Commission on Egg Nutrition. Washington, DC, USA (1976).
   Google Scholar
• Gillinov M, Nissen S. Heart 411: The Only Guide to Heart Health You’ ll Ever Need. Three Rivers, NY, USA (2012).
   Google Scholar
• Staprans I, Xian-Manh P, Rapp JH, Feingold KR. Oxidized cholesterol in the diet accelerates the development of aortic atherosclerosis in cholesterol-fed rabbits. Arterioscler. Thromb. Vasc. Biol. 18, 977–983 (1998).
   Google Scholar
• Imai H, Werthessen NT, Taylor CB, Lee KT. Angiotoxicity and arteriosclerosis due to contaminants of USP-grade cholesterol. Arch. Pathol. Lab. Med.11, 565–572 (1976).
   Google Scholar
• Morin RJ, Peng SK. Cholesterol oxides in plasma and tissues. In: Biological Effects of Cholesterol Oxides. CRC Press, FL, USA, 89–101 (1992).
   Google Scholar
• Steinberg D. Oxidative modification of LDL and atherogenesis. Circulation 95, 1062–1071 (1997).
   Google Scholar
• Sevanian A, McLeod LL. Cholesterol autoxidation in phospholipid membrane bilayers. Lipids 22, 627–636 (1987).
   Google Scholar
• Morrel DW, DiCorleto PE, Chisolm GM. Endothelial and smooth muscle cells alter low density lipoprotein in vitro by free radical oxidation. Arteriosclerosis 4, 357–364 (1984).
   Google Scholar
• Parthasarathy S, Printz DJ, Boyd D, Joy L, Steinberg D. Macrophage oxidation of low density lipoprotein generates a modified form recognized by the scavenger receptor. Arteriosclerosis 6, 505–510 (1986).
   Google Scholar
• Emanuel HA, Hassel CA, Addis PB, Bergmann SD, Zavoral JH. Plasma cholesterol oxidation products (oxysterols) in human subjects fed a meal rich in oxysterols. J. Food Sci. 56, 843–847 (1991).
   Google Scholar
• Zhou Q, Smith TL, Kummerow FA. Cytotoxicity of oxysterols on cultured smooth muscle cells from umbilical arteries. Proc. Soc. Exp. Bio. Med. 202, 75–80 (1993).
   Google Scholar
• Ross R. The pathogenesis of atherosclerosis: a perspective for the 1991s. Nature 362, 801–809 (1993).
   Google Scholar
• DeBakey ME, Diethrich EB, Garrett HE, McCutchen JJ. Surgical treatment of cerebrovascular disease. Postgrad. Med. 42, 218–230 (1967).
   Google Scholar
• Kummerow FA, Przybylski R, Wasowicz E. Changes in arterial membrane lipid composition may precede growth factor influence in the pathogenesis of atherosclerosis. Artery 21, 63–75 (1994).
   Google Scholar
• Kummerow FA, Cook LS, Wasowicz E, Jelen H. Changes in the phospholipid composition of the arterial cell can result in severe atherosclerotic lesions. J. Nutr. Biochem. 12, 602–607 (2001). • coronary artery bypass patients had a greater concentration of oxysterols in their plasma than age- and sex-matched controls without heart disease.
   Google Scholar
• Op den Kamp JAF. Lipid asymmetry in membranes. Annu. Rev. Biochem. 48, 47–71 (1979).
   Google Scholar
• Smith LL. Cholesterol Autoxidation. Plenum, NY, USA (1981).
   Google Scholar
• Calmarz P, Trejo J, Lapresta C, Lopez P. LDL oxidation and its association with carotid artery intima-media thickness and other cardiovascular risk factors in a sample of Spanish general population. Angiology doi:10.1177/0003319713488639 (2013) (Epub ahead of print).
   Google Scholar
• Zhou Q, Wasowicz E, Handler B, Fleischer L, Kummerow FA. An excess concentration of oxysterol in the plasma is cytotoxic to cultured endothelial cells. Atherosclerosis 149, 191–197 (2000).
   Google Scholar
• Zhou Q, Kummerow FA. Effects of 27-hydroxycholesterol on cellular sphingomyelin synthesis and C++ content in cultures smooth muscle cells. Biomed. Environ. Sci.10, 369–376 (1997).
   Google Scholar
• Javitt NB, Kok E, Burstein S, Cohen B, Kutscher J. 26-Hydroxycholesterol, identification and quantitation in human serum. J. Bio. Chem. 256, 12644–12646 (1981).
   Google Scholar
• Shah DO, Schulman JH. Interaction of calcium ions with lecithin and sphingomyelin monolayers. Lipids 2, 21–27 (1967).
   Google Scholar
• Mahfouz MM, Kummerow FA. Oxysterols and TBARS are among the LDL oxidation products which enhance thromboxane A2 synthesis by platelets. Prostaglandins Other Lipid Mediat.56, 197–217 (1998).
   Google Scholar
• Mahfouz MM, Kummerow FA. Oxidized low-density lipoprotein (LDL) enhances thromboxane A2 synthesis by platelets, but lysolecithin as a product of LDL oxidation has an inhibitory effect. Prostaglandins Other Lipid Mediat. 62, 183–200 (2000).
   Google Scholar
• Steinberg D. The Cholesterol Wars. Academic Press, NY, USA (2007).
   Google Scholar
• Kummerow FA, Olinescu RM, Fleischer L, Handler B, Shinkareva SV. The relationship of oxidized lipids to coronary artery stenosis. Atherosclerosis 149, 18–190 (2000).
   Google Scholar
• Ravnskov U, DiNicolantonio JJ, Harcombe Z, Kummerow FA, Okuyama H, Worm N. The questionable benefits of exchanging saturated fat with polyunsaturated. Mayo Clin. Proc. 89(4), 451–453 (2013).
   Google Scholar
• Mozaffarian D, Micha R, Wallace S. Effects on coronary heart disease of increasing polyunsturated fat in place of saturated fat: a systematic review and meta-analysis of randomized controlled trials. PLoS Med. 7, e1000252 (2010).
   Google Scholar
• Negative Population Growth. www.npg.org/facts/us_historical_pops.htm
   Google Scholar
• State Population Estimates and Demographic Components of Population Change: July 1, 1998 to July 1, 1999. www.census.gov/population/estimates/state/st-99-1.txt
   Google Scholar
• Ash M. US Department of Agriculture. Fats and vegetables oil consumption since 1912. http://factfinder2.census.gov/faces/tableservices/jsf/pages/productview.xhtml?pid=ACS_11_1YR_DP05&prodType=table
   Google Scholar
• Kunau WH, Holman RT. Polyunsaturated Fatty Acids. AOCS, Champaign, IL, USA (1977).
   Google Scholar
• Astrup A, Dyerberg J, Elwood P et al. The role of reducing intakes of saturated fat in the prevention of cardiovascular disease: where does the evidence stand in 2010? Am. J. Clin. Nutr. 93, 684–688 (2011).
   Google Scholar
• Lawrence G. Dietary fats and health: dietary recommendations in the context of scientific evidence. Adv. Nutr. 4, 294–302 (2013).
   Google Scholar
• Harcombe Z, Baker J, Davies B. Food for thought: have we been giving the wrong dietary advice?. Food Nutrit. Sci. 4, 240–244 (2013).
   Google Scholar
• Burr GO, Burr MM. On the nature and role of the fatty acids essential in nutrition. J. Bio. Chem. 86, 587 (1930).
   Google Scholar
• Kummerow FA. Hydrogenated fat for the world population. Prevention Control. 1, 157–164 (2005).
   Google Scholar
• James AT, Martin AJ. Gas-liquid partition chromatography: the separation and micro-estimation of ammonia and the methylamines. Biochem. J. 52, 238–242 (1952).
   Google Scholar
• Kummerow FA. The negative effects of hydrogenated trans fats and what to do about them. Atherosclerosis 205, 458–465 (2009).
   Google Scholar
• Johnston P, Johnson O, Kummerow FA. Occurrence of trans fatty acids in human tissue. Science 126, 698–699 (1957). •• in 1957, we recognized the presence of trans fatty acids in human tissue.
   Google Scholar
• Johnston PV, Johnson OC, Kummerow FA. Non-transfer of trans fatty acids from mother to young. Proc. Soc. Exp. Biol. Med. 96, 760–762 (1957).
   Google Scholar
• Johnston PV, Kummerow FA, Walton C. Origin of the trans fatty acids in human Tissue. Proc. Soc. Exp. Bio. Med. 99, 735–736 (1958).
   Google Scholar
• Johnston PV, Johnson OC, Kummerow FA. Deposition in tissues and fecal excretion of trans fatty acids in the rat. J. Nutr. 65, 13–23 (1958).
   Google Scholar
• Kummerow FA, Zhou Q, Mahfouz MM. Effects of trans fatty acids on calcium influx into human arterial cells. Am. J. Clin. Nutr. 70, 832–838 (1999).
   Google Scholar
• Kummerow FA, Zhou Q, Mahfouz MM, Smiricky MR, Grieshop CM, Schaeffer DJ. Trans fatty acids in the phospholipid of arterial cells. Life Sci. 74(22), 2707–2723 (2004).
   Google Scholar
• Innes SM, King DJ. Trans fatty acids in human milk are inversely associated with concentrations of essential all-cis n-6 and n-3 fatty acids and determine trans, but not n-6 and n-3, fatty acids in plasma lipids of breast fed infants. Am. J. Clin. Nutr. 70, 383–390 (1999).
   Google Scholar
• Stary HC. Natural history of calcium deposits in atherosclerosis progression and regression. Zeitschrift Kardiologie 89(2), S028–S035 (2000).
   Google Scholar
• Emken EA, Dutton HJ. Geometrical and Positional Fatty Acid Isomers. AOCS, Champaign, IL, USA (1979).
   Google Scholar
• Kummerow FA. Viewpoint of the report on the National Cholesterol Education Program Expert Panel on the Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. J. Am. Coll. Nutr. 12, 2–13 (1993).
   Google Scholar
• Kummerow FA, Mahfouz M, Zhou Q, Masterjohn C. The effects of trans fats on prostacyclin production. Scand. Cardiovasc. J. 47, 377–382 (2013).
   Google Scholar
• Linton MF, Fazio S. Cyclooxyenase-2 and atherosclerosis. Curr. Opin. Lipidol. 13, 497 (2002).
   Google Scholar
• Vane JR, Bakhle YS, Botting RM. Cyclooxygenase 1 and 2. Ann. Rev. Pharmacol. Toxicol. 38, 97 (1998).
   Google Scholar
• Cheng Y, Austin SC, Rocca B et al. Role of prostacyclin in the cardiovascular response to thromboxane A2. Science 296, 539 (2002).
   Google Scholar
• Anderson R. Chief Statistician. CDC. Washington DC, USA (2011). •• important because it provides information that trans fatty acids are causing heart failure.
   Google Scholar
• CDC: leading causes of death 1900–1908. www.cdc.gov/nchs/data/dvs/lead1900_98.pdf
   Google Scholar
• National Vital Statistics Report: the effect of revised populations on mortality statistics for the USA, 2000. www.cdc.gov/nchs/data/nvsr/nvsr51/nvsr51_09.pdf
   Google Scholar
• National Vital Statistics Report: deaths: final data for 2010. www.cdc.gov/nchs/data/nvsr/nvsr61/nvsr61_04.pdf
   Google Scholar
• Friedewald WT, Thom TJ. Decline of coronary heart disease mortality in the United States. Isr. J. Med. Sci. 22(3–4), 307–312 (1986).
   Google Scholar
• Hoyert DL, Xu JQ. Deaths: Preliminary Data. National Vital Statistics Reports. 61(6), National Center for Health Statistics, MD, USA (2012).
   Google Scholar
• Jain M. American Chemical Society, news release. 8th September (2013).
   Google Scholar
• Food labeling: trans fatty acids in nutrition labeling, nutrient content claims and health claims. Finale rule. Fed. Regist. 68, 41433–41506 (2003). • Trans fatty acids were recognized as risk factors for atherosclerosis.
   Google Scholar
• US FDA. Questions and answers about trans fat nutrition labeling. Office of Nutritional Products, Washington, DC, USA (2006).
   Google Scholar
• Harvard Health Publications. www.health.harvard.edu/press_releases/natural-trans-fatless-harmful-than-artificial-version
   Google Scholar
• Downs S, Thow A, Leeder S. The effectiveness of policies for reading dietary trans fat: a systematic review of the evidence. Bull. World Health Organ. 91, 262H–269H (2013).
   Google Scholar
• US FDA. Talking about trans fat: What you need to know. www.fda.gov/Food/IngredientsPackagingLabeling/LabelingNutrition/ucm079609.htm
   Google Scholar
• Mozaffarian D, Katan MB, Ascherio A, Stampfer MJ, Willett WC. Trans fatty acids and cardiovascular disease. N. Engl. J. Med. 354, 1601–1313 (2006).
   Google Scholar
• Vesper HW, Kuiper HC, Mirel LB, Johnson CL, Pirkle JL. Levels of plasma trans-fatty acids in non-Hispanic white adults in the United States in 2000 and 2009. JAMA 307, 562–563 (2012).
   Google Scholar
• CDC press release. www.cdc.gov/media/releases/2012/p0208_trans-fatty_acids.html
   Google Scholar
• US Government. Federal Register. 78, 67169–67175 (2013).
   Google Scholar